Custom AmpliSeqTM targeted resequencing to identify novel clincopathologic correlates in earlystage lung adenocarcinoma: A Yale lung cancer biorepository study
correlates and associations with prognosis are incompletely understood and the correlates of less common driver mutations and frequent passenger mutations (example STK11, p53) are only emerging. To better characterize

